American media: After the chip, the next area of the next area of China may be ...

Washington is still trapped in the Cold War. The US media broke the news that after the "Chip Act", US President Biden was preparing to sign an administrative order to help expand American biological manufacturing, and the goal is allegedly "targeting China".

Bloomberg News September 10 cited a person who was unwilling to disclose the name of the name, saying that the draft administrative order formulated a strategy of "supporting the US manufacturing", encouraging the use of biological systems to develop a series of products and materials, from new drugs from new drugs , Human tissue, biofuels to food are among them. The details about this order have not been made public.

Bloomberg report screenshots

Two people familiar with the matter said that the popularity of the new crown pneumonia's epidemic has given the US government a "urgency to formulate a clear and consistent industrial strategy". In addition to the field of healthcare, the United States will also be committed to promoting biological manufacturing of agriculture, energy and other industries.

According to reports, the content of the administrative order will include how the United States cultivates a well -trained professional force to create biological base products and materials. In addition, the Biden government plans to support the infrastructure of biological manufacturing, but it is unclear whether there are special funds to support the administrative order.

The report quoted people familiar with the matter that the White House would suggest to increase the level of domestic biological manufacturing in the United States, and ultimately achieve the goal of reducing prices and "strengthening supply chain security", which specifically mentioned "reducing dependence on China."

Bloomberg reported on the 10th that national security and intelligence officials were "specially worried about dependence on China's advanced biological manufacturing infrastructure." In the past 20 years, with the refinement of global division of labor, the drug manufacturing includes the treatment of drugs and antibiotics that treat hypertension, diabetes, and many of them have been transferred from the United States, Europe and Japan to China. Some American medical experts are worried that "the United States depends on Chinese drugs is a big problem." But in fact, the United States has one of the most powerful biotechnology industries in the world and is leading in R & D. The number of Chinese innovative biopharmaceuticals is still very low, and it will not threaten the global status of the United States in the short term.

If the Biden government signed this administrative order, it is obvious that it will become the latest initiative to curb China's development in the high -tech field. On August 9, Biden officially signed the "Chip and Science Act" in the White House to provide huge subsidies for the American chip industry to promote differentiated industrial support policies. In addition, the U.S. government is still trying to engage in the so -called chip "Quartet Alliance" in Latin South Korea, Japan, and Taiwan. Chinese Foreign Affairs spokesman Wang Wenbin said that the "chip bill" in the United States shows a strong geopolitical color and is another example of the United States for economic stress. This approach will only distort the global semiconductor supply chain and disturb the international trade. China has resolutely opposed it.

The U.S. government seems to be obsessed with "imaginary enemies" in the field of high -tech fields. "For China and the United States, technology is the largest battlefield." Bloomberg reported another report on the 10th that US Finance Minister Yelun emphasized in a speech on Thursday that the US government used 1.9%of GDP for GDP in the 1960s. Research and development is part of the reason for competing with the Soviet Union to land on the moon. "In recent years, it has only spent one -third of them (R & D expenses of that year). The retreat of public research and development is estimated to cause US $ 200 billion in economic output losses each year. At the same time, competitors in China and other parts of the world It is moving forward, "Yellen said.

Global Times-Global Network reporter Ma Qingyan

- END -